1
Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's Lymphoma
Condition(s): Lymphoma, Non-Hodgkin Last Updated: August 9, 2012Completed
303 Clinical Trials for: “Cadexomer Iodine”, Page 1 of 16
Hide Studies Not Seeking New Volunteers
2
Povidone Iodine and Cesarean Section Wound Infections
Condition(s): Wound Infections Last Updated: October 3, 2012Completed
3
Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate
Condition(s): Prostate Cancer Last Updated: February 8, 2013Completed
4
Study of Chlorhexidine Gluconate as a Preoperative Antisepsis
Condition(s): Surgical Site Infection Last Updated: December 15, 2011Recruiting
5
Comparison of Iodine + Isopropyl Alcohol Versus Iodine + Antimicrobial Sealant for Skin Preparation
Condition(s): Surgical Site Infection Last Updated: April 26, 2010Recruiting
6
Dosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade Histologies
Condition(s): Lymphoma, Non-Hodgkin Last Updated: May 24, 2012Completed
7
Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine
Condition(s): Viral Conjunctivitis Last Updated: August 10, 2010Completed
8
Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma
Condition(s): Thyroid Cancer Last Updated: March 1, 2013Active, not recruiting
9
Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received Rituximab
Condition(s): Lymphoma, Non-Hodgkin; Non-Hodgkin's Lymphoma Last Updated: February 9, 2012Completed
10
Soap Versus Normal Salin Plus Povidone-iodine in Ununion Wound
Condition(s): Wound Last Updated: October 5, 2012Recruiting
11
Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma
Condition(s): Lymphoma, Non-Hodgkin; Non-Hodgkin's Lymphoma Last Updated: December 9, 2010Terminated
12
Hepatocellular Carcinoma Treated With Iodine-125 Implantation
Condition(s): Liver Carcinoma Last Updated: October 26, 2012Completed
13
Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma.
Condition(s): Lymphoma, Non-Hodgkin Last Updated: March 14, 2013Completed
14
Testicular Function After Iodine 131 Therapy in Papillary Carcinoma Patients
Condition(s): Thyroid Neoplasms Last Updated: February 22, 2011Completed
15
Comparative Efficacy of Different Regimens of PVPI 5% Eye Drops Instillation in Reducing Conjunctival Bacterial Flora
Condition(s): Eye Infections Last Updated: November 28, 2012Recruiting
16
The Counter-irritating Efficacy of Topical Povidone-iodine in Thermal Burns
Condition(s): Skin Burns Last Updated: May 9, 2011Not yet recruiting
17
Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition(s): Anaplastic Large Cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Splenic Marginal Zone Lymphoma; Waldenström Macroglobulinemia Last Updated: September 5, 2012Active, not recruiting
18
Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition(s): Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Splenic Marginal Zone Lymphoma; Waldenström Macroglobulinemia Last Updated: September 5, 2012Active, not recruiting
19
Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 Antibody
Condition(s): Lymphoma, Non-Hodgkin Last Updated: May 31, 2012Active, not recruiting
20
Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's Lymphoma
Condition(s): Non-Hodgkin's Lymphoma Last Updated: July 16, 2009No longer available
